Douglas Stephen Harrington
Physician at Camino Ibiza, San Clemente, CA
License number
Colorado 23614
Issued Date
Jan 8, 1981
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
906 Camino Ibiza, San Clemente, CA 92672
Professional information
Dr. Douglas S Harrington, Irvine CA - MD (Doctor of Medicine)
Specialties:
Hematology, Hematopathology
Address:
9805 Research Dr, Irvine 92618
(949) 547-3140 (Phone)
STRATEGIC BUSINESS SOLUTIONS
906 Camino Ibiza, San Clemente 92672
(949) 369-1127 (Phone), (949) 498-2305 (Fax)
(949) 547-3140 (Phone)
STRATEGIC BUSINESS SOLUTIONS
906 Camino Ibiza, San Clemente 92672
(949) 369-1127 (Phone), (949) 498-2305 (Fax)
Certifications:
Anatomic & Clinical Pathology, 1984, Hematology & Pathology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Colorado At Denver
Graduated: 1978
North Canterbury Hosp
U Ariz Hlth Sci Ctr
U Colo Hlth Sci Ctr
U Nebr Hlth Sci Ctr
University of Colorado At Denver
Graduated: 1978
North Canterbury Hosp
U Ariz Hlth Sci Ctr
U Colo Hlth Sci Ctr
U Nebr Hlth Sci Ctr
Automated Method For Image Analysis Of Residual Protein
US Patent:
6671393, Dec 30, 2003
Filed:
Dec 10, 2001
Appl. No.:
10/014006
Inventors:
Presley Hays - Pasadena CA
Michal L. Peri - Irvine CA
Douglas Harrington - San Clemente CA
Michal L. Peri - Irvine CA
Douglas Harrington - San Clemente CA
Assignee:
ChromaVision Medical Systems, Inc. - San Juan Capistrano CA
International Classification:
G06K 900
US Classification:
382128
Abstract:
An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with -naphthol butyrate with or without fluoride.
Automated Method For Image Analysis Of Residual Protein
US Patent:
7660449, Feb 9, 2010
Filed:
Apr 14, 2008
Appl. No.:
12/102665
Inventors:
Presley Hays - Pasadena CA, US
Michal L. Peri - Irvine CA, US
Douglas Harrington - San Clemente CA, US
Michal L. Peri - Irvine CA, US
Douglas Harrington - San Clemente CA, US
Assignee:
Carl Zeiss MicroImaging GmbH - Jena
International Classification:
G06K 9/00
US Classification:
382128
Abstract:
A method for measuring residual protein in a cellular specimen including obtaining a low magnification image of a candidate object of interest, filtering the candidate object of interest pixels with a low pass filter, morphologically processing the candidate object of interest pixels to identify artifact pixels, identifying the candidate object of interest by eliminating artifact pixels, acquiring a higher magnification image of the subsample for the candidate object of interest, transforming pixels of the higher magnification image in a first color space to a second color space to differentiate higher magnification candidate object of interest pixels from background pixels, identifying an object of interest from the candidate object of interest pixels in the second color space, and determining the optical density of the protein in a cell contained in a subsample, wherein the optical density is indicative of the residual component of a cellular protein.
Automated Method For Image Analysis Of Residual Protein
US Patent:
6330349, Dec 11, 2001
Filed:
Jul 7, 2000
Appl. No.:
9/612022
Inventors:
Presley Hays - Pasadena CA
Michal L. Peri - Irvine CA
Douglas Harrington - San Clemente CA
Michal L. Peri - Irvine CA
Douglas Harrington - San Clemente CA
Assignee:
ChromaVision Medical Systems, Inc. - San Juan Capistrano CA
International Classification:
G06K 900
US Classification:
382128
Abstract:
An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with. alpha. -naphthol butyrate with or without fluoride.
Automated Method For Image Analysis Of Residual Protein
US Patent:
7359536, Apr 15, 2008
Filed:
Dec 5, 2003
Appl. No.:
10/728698
Inventors:
Presley Hays - Pasadena CA, US
Michal L. Peri - Irvine CA, US
Douglas Harrington - San Clemente CA, US
Michal L. Peri - Irvine CA, US
Douglas Harrington - San Clemente CA, US
Assignee:
Carl Zeiss MicroImaging AIS, Inc. - Thornwood NY
International Classification:
G06K 9/00
US Classification:
382128, 382308
Abstract:
An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with α-naphthol butyrate with or without fluoride.